Michael P. Stansky
Director · TriSalus Life Sciences, Inc.
- 2026
- May 18, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael P. Stansky files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mary T. Szela - $307K in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- David Patience - $32K in TLSI purchases and sales in the last 12 months
- Richard Marshak - $17K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael P. Stansky?
Michael P. Stansky is a corporate insider, tracked as Director of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael P. Stansky last file a Form 4?
The most recent primary Form 4 on record is dated 18 May 2026, one of 4 filings going back to 2026.
Has Michael P. Stansky been buying or selling stock?
Recorded transactions: 4 open-market purchases ($3.01M) and 0 open-market sales across all tracked filings.
